Dr. Monia El Aradhi, an assistant professor at the Human and Experimental Pathology Laboratory at the Pasteur Institute in Tunis, has won the first prize in the researcher category at the 38th International Human Papillomavirus (HPV) Conference. The conference took place in Athens, Greece, from October 22 to 25, 2026. Her research, titled "Genetic variability of HPV-16 L1 protein in Tunisian cervical samples and its relation to vaccine-targeted regions," was recognized for its significance in understanding the genetic variations of HPV-16.
The research highlights the importance of studying the genetic variations of HPV-16 and their role in understanding the mechanisms of protection provided by vaccines, which can contribute to the development of scientific knowledge related to cervical cancer prevention. Dr. El Aradhi's study focused on the genetic variability of HPV-16 in cervical samples from Tunisian women and its relationship to vaccine-targeted regions.
The International HPV Conference, organized by the International Society for HPV and Cervical Cancer Prevention, brought together researchers and experts from around the world to share knowledge and present the latest research findings on HPV and related diseases. The conference provided a platform for scientists to exchange ideas and discuss recent advances in the field.
Dr. El Aradhi's award is a testament to the quality of research conducted in Tunisia and reflects the country's growing reputation in the scientific community. Her research has the potential to inform the development of effective vaccines and prevention strategies against cervical cancer.
Cervical cancer is a significant public health concern in Tunisia and many other countries. According to the World Health Organization (WHO), cervical cancer is the fourth most common cancer affecting women worldwide. The WHO recommends vaccination against HPV as a key strategy for preventing cervical cancer.
Dr. El Aradhi's research has been recognized for its contribution to the understanding of HPV-16 genetic variability and its implications for vaccine development. Her study provides valuable insights into the genetic characteristics of HPV-16 in Tunisian women, which can inform the development of targeted prevention strategies.
The award-winning research is a significant achievement for Dr. El Aradhi and the Pasteur Institute in Tunis. It demonstrates the institute's commitment to conducting high-quality research and its contribution to the global scientific community.
Key points
- Dr. Monia El Aradhi wins first prize at the 38th International HPV Conference for her research on HPV-16 genetic variability.
- The research highlights the importance of studying genetic variations of HPV-16 for cervical cancer prevention.
- The study provides valuable insights into the genetic characteristics of HPV-16 in Tunisian women.
